Cargando…
Engineered RNase P Ribozymes Effectively Inhibit Human Cytomegalovirus Gene Expression and Replication
RNase P ribozyme can be engineered to be a sequence-specific gene-targeting agent with promising application in both basic research and clinical settings. By using an in vitro selection system, we have previously generated RNase P ribozyme variants that have better catalytic activity in cleaving an...
Autores principales: | Yang, Zhu, Vu, Gia-Phong, Qian, Hua, Chen, Yuan-Chuan, Wang, Yu, Reeves, Michael, Zen, Ke, Liu, Fenyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074932/ https://www.ncbi.nlm.nih.gov/pubmed/24932966 http://dx.doi.org/10.3390/v6062376 |
Ejemplares similares
-
Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme
por: Zeng, Wenbo, et al.
Publicado: (2012) -
RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins
por: Yang, Zhu, et al.
Publicado: (2015) -
Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals
por: Li, Wei, et al.
Publicado: (2018) -
Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant
por: Sun, Xu, et al.
Publicado: (2017) -
A RNase P Ribozyme Inhibits Gene Expression and Replication of Hepatitis B Virus in Cultured Cells
por: Yan, Bin, et al.
Publicado: (2023)